Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JK-1201I in Small Cell Lung Cancer
NCT05158491Phase 2Unknown
- Sponsor
- JenKem Technology
- Start
- Nov 2021
- Primary completion
- Dec 2022
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JK-1201I in small cell lung cancer (SCLC), sponsored by JenKem Technology. Status: unknown.
02
Drugs
JK-1201I
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT05158491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05158491.